CGTX: Cognition Therapeutics Narxning sof foyda o‘sishiga nisbati
Cognition Therapeutics (CGTX) laboratoriya xavfsizligi va ofis raqamlashtiruvi orqali ekologik standartlarga rioya qiladi. Ilmiy hamjamiyatda Cognition Therapeutics (CGTX) Altsgeymer kasalligida neyron aloqalarini tiklash usullarini tadqiq qilayotgani uchun qadrlanadi. Grantlar va patentlarning samarali boshqaruvi aktivning salohiyatini tasdiqlaydi, bu esa PEG koeffitsiyentining o'zgarishini qo'llab-quvvatlaydi. 0.00 qiymati ushbu metrikaning darajasini ko'rsatib, aksiyalarning o'sishiga nisbatan qadrsizlanganligini aniqlashga yordam beradi.
Cognition Therapeutics, Inc. (CGTX) kompaniyasining tahliliy kesimlari
- joriy kotirovkalar va o'rtacha qiymat prognozi:
- bozor kapitallashuvi haqida ma'lumot:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Jamlagan qarzning kapitalga nisbati Cognition Therapeutics|CGTX - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga koeffitsiyenti Cognition Therapeutics Inc.|CGTX - Kompaniya qarzlari|Balans qiymatiga qarzlar Cognition Therapeutics|CGTX - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzdorligi Cognition Therapeutics|Oraliq qoplash koeffitsiyenti cogrx.com
- sof daromad va qiymat multiplikatorlari ko'rsatkichlari:
CGTX - Sof daromad|Kelajakdagi sof foyda Cognition Therapeutics|CGTX - P/E multiplikatori|Kelajakdagi narx-foyda multiplikatori cogrx.com|CGTX - PEG multiplikatori|Kompaniya qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati Cognition Therapeutics|CGTX - Foizlar, soliqlar va eskirish to'lanishidan oldingi foyda|Sirpanuvchi yil uchun bir aksiya uchun foyda Cognition Therapeutics|CGTX - Bir aksiya uchun sof foyda (EPS TTM)|Choraklik EPS foyda o'sishi cogrx.com|CGTX - Joriy yilda bir aksiya uchun foyda o'sishi|Kelgusi yil uchun bir aksiya uchun sof foydaning o'zgarishi prognozi Cognition Therapeutics
- emitentning tushumi va sotuvlari tafsilotlari:
Kompaniyaning fundamental tahlili:CGTX - cogrx.com
PEG koeffitsiyenti aksiyaning bozor qiymatini uning foyda o'sish sur'ati bilan solishtirib, aktivning o'sish dinamikasiga nisbatan qanchalik past baholanganlik darajasini aniqlaydi. Dori vositalarini ishlab chiqish bo'yicha barqaror AQSh huquqiy bazasi doirasida Cognition Therapeutics (CGTX) tashqi xatarlarni minimallashtiradi, bu esa PEG koeffitsiyenti o'zgarishlarini yuqori kapitalizatsiya potentsialiga ega bo'lgan, past baholangan "raketalar"ni aniqlash uchun asosiy ko'rsatkichga aylantiradi.
Cognition Therapeutics raqobatchilari
BIIB - O‘sish sur’atiga tuzatilgan narx-foyda|PEG multiplikatori NBIX (Neurocrine Biosciences Inc)|Narxning sof foyda o‘sishiga nisbati Regencell Corp|AXSM - Narxning foydaga va o‘sish sur’atiga nisbati|ACAD (acadia-pharm.com) - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|XENE: PEG multiplikatori|VKTX - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narx-foyda va o‘sish multiplikatori SUPN|CPRX (Catalyst Corp) - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|PEG multiplikatori DNLI|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati harmonybiosciences.com|Narxning foydaga va o‘sish sur’atiga nisbati Biohaven BHVN|Amylyx Pharmaceuticals Inc (AMLX) - O‘sish sur’atiga tuzatilgan narx-foyda|TRVI - Narxning foydaga va o‘sish sur’atiga nisbati|PRAX (Praxis Corp) - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|AVXL (Anavex Life Sciences) - Narx-foyda va o‘sish multiplikatori|ceribell.com - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narx-foyda va o‘sish multiplikatori PRTA|ALEC (Alector Therapeutics) - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|PEG multiplikatori ANNX|OMER (omeros.com) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori NGNE (Neurogene Inc.)|acimmune.com (ACIU) - O‘sish sur’atiga tuzatilgan narx-foyda|VYGR - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti NMRA (Neumora)|SCLX: PEG multiplikatori|Tevogen Bio Inc. (TVGN) - PEG multiplikatori|Narxning foydaga va o‘sish sur’atiga nisbati Alpha Cognition Inc|inhibikase.com - Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|PEG multiplikatori SAVA|ASRT - O‘sish sur’atiga tuzatilgan narx-foyda|Coya Therapeutics - Narx-foyda va o‘sish multiplikatori|PEG multiplikatori VistaGen Therapeutics, Inc. VTGN|OVID: Narx-foyda va o‘sish multiplikatori|acumenpharm.com - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|CRVO: PEG multiplikatori|ATHE - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|CLNN (Clene Inc) - PEG multiplikatori|Narx-foyda va o‘sish multiplikatori PepGen Corp (PEPG)|Narxning foydaga va o‘sish sur’atiga nisbati Jupiter Neurosciences Inc (JUNS)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati relmada.com|PEG multiplikatori ANVS (Annovis Bio)|GRCE - Narx-foyda va o‘sish multiplikatori|Firefly Neuroscience Inc - PEG multiplikatori|Narxning sof foyda o‘sishiga nisbati Klotho Neurosciences Inc (KLTO)|NRSN (neurosense-tx.com) - Narx-foyda va o‘sish multiplikatori|RVPH: Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori MTVA|O‘sishni hisobga olgan narx-foyda koeffitsiyenti NRXS (NeurAxis Inc.)|Narxning foydaga va o‘sish sur’atiga nisbati Helius Medical (HSDT)|passagebio.com - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|PEG multiplikatori NEUP (Neuphoria Therapeutics)|minervaneurosciences.com (NERV) - O‘sish sur’atiga tuzatilgan narx-foyda|ATHA: Narx-foyda va o‘sish multiplikatori|ADXN - PEG multiplikatori|alzamend.com (ALZN) - Narxning foydaga va o‘sish sur’atiga nisbati|Cyclerion Therapeutics, Inc. - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Protagenic Therapeutics Inc.|O‘sish sur’atiga tuzatilgan narx-foyda Pasithea KTTA|PEG multiplikatori CRGT|Narx-foyda va o‘sish multiplikatori Avenue Therapeutics Inc. ATXI|Narxning foydaga va o‘sish sur’atiga nisbati Brainstorm Cell Therapeutics, Inc. BCLI|Cara Therapeutics Inc (CARA) - O‘sish sur’atiga tuzatilgan narx-foyda|Chromocell Therapeutics - PEG multiplikatori|Narxning sof foyda o‘sishiga nisbati Eliem Therapeutics (ELYM)|intracellulartherapies.com (ITCI) - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sishni hisobga olgan narx-foyda koeffitsiyenti LBPH|MRNS (Marinus) - PEG multiplikatori|NKGen Biotech Corp (NKGN) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narx-foyda va o‘sish multiplikatori NRBO (NeuroBo Pharmaceuticals)|Kompaniya qiymatining foyda o‘sish sur’atiga nisbati SAGE|PEG multiplikatori SNPX (Synaptogenix)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Trevena Inc. (TRVN)|VIGL - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atiga tuzatilgan narx-foyda Anew Medical Inc.|Cerevel Therapeutics (CERE) - Narxning foydaga va o‘sish sur’atiga nisbati
